9H-pyrido[2,3-b]indole | CAS:244-76-8
9H-pyrido[2,3-b]indole
- 名称:9H-吡啶并[2,3-b]吲哚 | 9H-pyrido[2,3-b]indole
- CAS号:244-76-8
- 别名:1H-Pyrido[2,3-b]indole; 1,9-Diazafluorene; 1-Azacarbazole; 9H-1,9-Diazafluorene; NSC 67064; alpha-Carboline
- 分子式:C11H8N2
- 分子量:168.19
- EINESC号:205-960-6
产品描述
物理化学性质
熔点 | 219-220 ºC |
---|---|
沸点 | 373 ºC |
闪点 | 172 ºC |
密度 | 1.301 |
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
更多
名称 | CAS号 |
---|
更多
文章
同行评议文献
Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs.Kristin N Adams et al.The Journal of infectious diseases, 210(3), 456-466 (2014-02-18)
The efflux pump inhibitor timcodar improves the potency of antimycobacterial agents.Trudy H Grossman et al.Antimicrobial agents and chemotherapy, 59(3), 1534-1541 (2014-12-24)
Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein.Yasuhiro Horita et al.Antimicrobial agents and chemotherapy, 58(6), 3168-3176 (2014-03-26)
Bacteriological characterization of a Mycobacterium parascrofulaceum strain isolated from a Chinese pneumonia patient.Guan Liu et al.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 25, 82-87 (2014-05-27)
Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry.Hyo-Ji Kim et al.Journal of pharmaceutical and biomedical analysis, 102, 9-16 (2014-09-15)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!